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Tandem-Mass-Tag Based Proteomic Analysis Facilitates
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The analysis of nanoparticles’ biocompatibility and immunogenicity is mostly
performed under a healthy condition. However, more clinically relevant
evaluation conducted under pathological condition is less known. Here, the
immunogenicity and bio–nano interactions of porous silicon nanoparticles
(PSi NPs) are evaluated in an acute liver inflammation mice model.
Interestingly, a new mechanism in which PSi NPs can remit the hepatocellular
damage and inflammation activation in a surface dependent manner through
protein corona formation, which perturbs the inflammation by capturing the
pro-inflammatory signaling proteins that are inordinately excreted or exposed
under pathological condition, is found. This signal sequestration further
attenuates the nuclear factor 𝜿B pathway activation and cytokines production
from macrophages. Hence, the study proposes a potential mechanism for
elucidating the altered immunogenicity of nanomaterials under pathological
conditions, which might further offer insights to establish harmonized
standards for assessing the biosafety of biomaterials in a disease-specific or
personalized manner.
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The prevailing investigation and appli-
cation of nanoparticles (NPs) rapidly
revolutionized many areas, especially,
biomedicine technology. Whilst the perpet-
ual effort in engineering different nanosys-
tems with therapeutic advantages, another
pivotal factor for their successful clinical
translation is the thorough understanding
and manipulation of their biocompatibil-
ity and biological responses.[1] Previous
studies scrutinized biocompatibility and
immunogenicity of various types of NPs
under healthy condition,[2] and with the
deeper understanding of NP−biosystem
interactions, there has been an increasing
interest to explore the potential impact of
the NPs under diseased conditions, which
is more clinically relevant.[3] For example,
previous studies have demonstrated that
the bio-fate of NPs was altered under a dis-
eased condition,[4] and results in impinging
on the disease prognosis.[5,6] Therefore, it is
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meritorious to ponder and deliberate the biological responses
of NPs within lesion sites for a better mechanistic basis
understanding.
The clinical translation of porous silicon (PSi) particles has
been expanding at a high pace during the past 20 years.[7] Several
PSi based clinical trials have been conducted to treat hepatocellu-
lar carcinoma and pancreatic cancer, where PSi are locally admin-
istrated to targeted sites.[8] However, previous studies have shown
that the crosstalk between NPs and surrounding diseased tis-
sue may improve the disease prognosis by reversely reprogram-
ming the detrimental microenvironment, such as modulating
the inflammatory polarization.[6,9] Similarly, we have previously
discovered that the administration of porous silicon nanoparti-
cles (PSi NPs) within inflammatory conditions might affect the
disease outcome to different extents,[10,11] despite their satisfac-
tory biocompatibility and immunogenicity under healthy ani-
mal models.[12] Yet, the rationale behind this phenomenon re-
mains elusive. Therefore, a systematic study on investigating
the potent biological response to PSi NPs under diseased con-
dition may not only accelerate the clinical translation of PSi NPs,
but also provide insights to further understand the bio–nano
interactions.
A large interest and a plethora of previous studies have been
reported to investigate the effect of the bio–nano interactions
in lesion sites.[13,14] With the advent of proteomic investigation,
the protein corona complex around the NPs has proven to be a
critical factor in explaining this phenomenon.[15] This extended
paradigm proposes that protein corona formation under a dis-
eased condition has a role not only in altering the biocompatibil-
ity and pharmacokinetics properties of NPs, but also interfering
with the surrounding biological microenvironment.[16] Based on
this strategy, previous studies applied a variety of different NPs
as a “nano-concentrator” to exert both diagnostic[13,17] and thera-
peutic functions.[18,19] Yet, systematic investigations are still rela-
tively less for aligning the particular parameters of nanomaterials
in determining the effect on biological responses of NPs under
diseased conditions, and to date there is no report in the liter-
ature demonstrating the corresponding information about PSi
NPs.
In this study, we purpose that PSi NPs administration un-
der conditions of acute liver inflammation (ALI, pre-induced)
could attenuate the liver necrosis and inflammatory response.
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We determined the importance of three critical parameters: sur-
face hydrophobicity, porosity, and surface reducibility of PSi NPs.
Herein, we propose that the inflammation attenuation capabil-
ity of PSi NPs under ALI condition is positively correlated with
the protein corona formation process, and this protein scaveng-
ing efficiency is more correlated with the porosity, rather than
surface hydrophobicity of the NPs, whereas the reductive bonds
within PSi NPs show minimal effects on attenuating the in-
flammation. The detailed composition of protein corona com-
position of each type of PSi NPs under ALI condition is con-
firmed by tandem-mass-tag (TMT) assisted proteomic study and
the following R-language facilitated analysis. In contrast to ear-
lier works, which usually struggled to quantify hundreds to
few thousands proteins, we extended this number to over 4000
types of proteins from each type of PSi corona complex, as
such may provide deeper insight into the corona proteome and
the bio–nano interactions under diseased condition. In conclu-
sion, we identify the role of the protein corona in determining
the immunogenicity of PSi NPs under an ALI condition, high-
lighting the role of PSi NPs in affecting the prognosis of the
disease.
Three different PSi NPs with distinguished surface properties
were produced, namely thermal oxidized PSi NPs (TO), thermal
carbonized PSi NPs (TC), and undecylenic acid modified ther-
mal hydrocarbonized PSi NPs (Un). They separately represent
the majorly applied surface stabilizing methods, and obtain dis-
tinguished surface hydrophobicity properties (from hydrophilic
to hydrophobic: TO, TC, Un). The difference of the surface hy-
drophobicity was confirmed through water contact angle (WCA)
by placing a 5 µL droplet of water on a glass slide covered with
dried PSi NPs film. Un obtained the most hydrophobic surface
with WCA of 122° ± 6° compared to 62° ± 4° of TC and of 51°
± 5° of TO (Figure 1a, Table S1, Supporting Information). Trans-
mission electron microscopy (TEM) showed the morphology of
different PSi NPs (Figure 1b). The hydrodynamic size and sur-
face zeta-potential of different PSi NPs were characterized with
dynamic light scattering (DLS) coupled zeta-potential analyzer,
while their corresponding porosity was studied using N2 adsorp-
tion/desorption method. These NPs represent the commonly
applied surface stabilization methods to obtain a similar size,
zeta-potential, and porosity (Table S1, Figure S1a, Supporting In-
formation), but distinguished surface chemistries.[20–22] Fourier
transform infrared spectroscopy was conducted to confirm the
surface chemistries of different PSi (Figure S1b, Supporting In-
formation). Bands from TO were found at 3740 and 882 cm−1,
which were respectively attributed to Si–OH and –OySi–Hx.
[20]
The typical 𝜈(C = O) band at 1715 cm−1 from Un confirmed
the successful undecylenic acid hydrosilylation,[22] and this band
was also visible from TC, which was due to the acetylene treat-
ment and the following high temperature from the annealing
process.[21] Hydrides (–OySi–Hx) remaining on the surface of the
NPs can be confirmed by the PSi hydride stretch region at 2100–
2300 cm−1.[23] Further colloidal stability test was conducted in
human plasma and the results confirmed that all three type of
PSi NPs obtained a satisfied plasma stability within 1.5 h (Figure
S1c,d, Supporting Information).
We found that PSi NPs mainly accumulate in liver when it
is administrated intravenously.[10] Therefore, to better investi-
gate the immunomodulatory effects of different PSi NPs within
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Figure 1. Characterization of different PSi NPs. a) Contact angle of water droplet on different PSi NPs film. Glass slides were covered with different types
of dried PSi NPs to form into PSi NPs film. The WCA of different surface chemistries was estimated by placing a 5 µL droplet of water on corresponding
PSi film, photograph of the droplet was taken and analyzed with Attension Theta Optical Tensiometer. The water contact angle of different PSi confirmed
the surface hydrophobicity properties of each type of NPs where TO is the most hydrophilic NPs and Un is the most hydrophobic NPs. b) Graphic
illustration of the surface chemistries of the different PSi NPs and the corresponding TEM images. The TEM images confirmed the porous structure of
each type of PSi NPs and the observed morphology and size are in consistence with their corresponding hydrodynamic size obtained via DLS method.
pre-existing lesion sites, ALI was induced in mice by adminis-
tration of acetaminophen (APAP). High dose of APAP results in
hepatocellular necrosis within 1.5 h,[24] which further amplifies
the inflammatory process and then aggravates liver injury.[25] 3
h post APAP administration, TO, TC, and Un at different con-
centrations (0.3 or 3 mg kg−1 as low (L) or high (H) concentra-
tion, respectively) were injected in ALI mice via i.v. Healthy or
ALI mice without PSi NPs treatment were referred as healthy or
ALI group. 48 h after PSi NPs administration, blood and tissues
were collected for further study.
We first evaluated the systemic changes of each group. ALI
group showed a significant increase in liver index, while the in-
jection of PSi NPs had limited effects on both body weights and
liver index compared to ALI group (Figure S2a,b, Supporting In-
formation). In the hematologic test, ALI group showed a signifi-
cantly enhanced total white blood cells (WBC) number (p= 0.013)
in comparison with the healthy group, as a result of successful
ALI establishment.[26] Comparing to ALI group, none of the PSi
NPs promoted any further increase in the WBC number (Fig-
ure 2a). Similarly, no significantWBC composition changes were
observed after PSi administration since the percentage of three
main types of WBC, namely granulocytes (Figure 2b), monocytes
(Figure 2c), and lymphocytes (Figure 2d), remained comparable
to ALI group. In addition, hematoxylin and eosin (H&E) staining
and TdT-mediated dUTP Nick-End labeling of liver sections also
suggest that administration of PSi in ALI mice did not exacer-
bate liver damage (Figure S3a,b, Supporting Information). Inter-
estingly, the serum biochemical analysis showed a significant de-
crease (Figure 2f) of the aspartate aminotransferase (AST) value
formost of the PSi-treatedmice compared to theALI group, while
alanine aminotransferase (ALT) value wasmodestly affected (Fig-
ure 2e), resulting into an overall reduced AST/ALT value, which
was statistically different in the Un H group (Figure 2g). A simi-
lar effect was observed for the alkaline phosphatase (ALP), where
administration of high concentrationUn showed a significant de-
crease comparing to ALI group (Figure 2h). Moreover, the injec-
tion of TO and Un at high concentration also led to an enhanced
glutathione (GSH) level in mice suffering from ALI (p = 0.032
for TO H and p = 0.019 for Un h, Figure 2i). Overall, PSi NPs
injection under an ALI condition slightly reduces liver injurious
extents, where TO and Un had an overall better capability com-
paring to TC.
We hypothesized the improved disease outcome of PSi NPs
can be mainly attributed to the subsequent pro-inflammatory
cascade responded to hepatocellular necrosis.[24,25,27] To confirm
this, quantitative real-time polymerase chain reaction (qPCR)was
applied to quantify the mRNA expression level associated with
key pro-inflammatory cytokines and chemokines, including IL-
1𝛽, IL-6, tumor necrosis factor 𝛼 (TNF-𝛼), chemokine (C-X-C
motif) ligand 1 (CXCL-1), and chemokine (C-C motif) ligand 2
(CCL-2). Comparing to a healthy condition, mice suffering from
ALI exhibited 2–5-folds higher mRNA expression for the indi-
cated cytokines and chemokines. However, PSi administration
showed a surface chemistry dependent immunomodulatory ef-
fect in the inflammatory condition, where TO (H) group signif-
icantly reduced the TNF-𝛼 and IL-6 expression, whilst Un (H)
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Figure 2. Administration of PSi NPs affected the disease outcome of ALI. a) Administration of PSi NPs under an inflammatory condition, showing
limited effect on secondary WBC number enhancement. In vivo blood immune cell alterations after ALI establishment and PSi NPs administration. Blood
samples were collected, as described above. Percentage of three main types of leukocytes, namely b) monocytes, c) granulocytes, and d) lymphocytes,
in total WBC were analyzed. e) Serum ALT as a measure of liver injury. PSi administration under ALI condition showed no significant effect on neither
deteriorating nor attenuating ALT value. f) Determination of serum AST level from different groups, where TO L, TO h, TC L, Un L, and Un H were
statistically significant different. g) Yielded AST/ALT value of different group. Un H group reached statistical significance. h) Serum ALP value of Un H
group was significantly lower than ALI group. i) The hepatocellular GSH value from TO H and Un H group were significantly higher than ALI group. All
data in the graphs are shown as mean ± SD from five independent replicates. *p < 0.05, **p < 0.01, ***p < 0.0005, and ****p < 0.0001 compared with
ALI group (two-tailed Student’s t-test).
group reduced TNF-𝛼, IL-6, and IL-1𝛽 expression, yet TC at both
concentrations showed a sparing effect (Figure 3a). This was in
consistence with the aforementioned results that TO (with the
most hydrophilic surface) and Un (with the most hydrophobic
surface) showed a more significant role in reducing the inflam-
matory response comparing to TC.
Enzyme linked immunosorbent assay (ELISA) was conducted
to quantify the amount of threemain pro-inflammatory cytokines
(TNF-𝛼, IL-6, and IL-1𝛽) in the liver. Similarly, TO and Un ad-
ministration downregulated all three cytokines production in a
PSi NPs’ concentration dependent manner, whereas this phe-
nomenon from TC was marginally present, as TC at low con-
centration slightly reduced the IL-1𝛽 production, while high con-
centration of TC only slightly inhibited TNF-𝛼 production (Fig-
ure 3b–d). Taken altogether, the phenomenon of PSi surface de-
pendent inflammation attenuation can partly explain the above-
mentioned injury mitigation. However, this inflammation miti-
gation cannot be linearly correlated with the hydrophobicity of
the PSi surfaces.
Since the appearance or increase of acute phase proteins in
plasma, which comprises mostly pro-inflammatory signaling
proteins, is one of the prominent features for ALI,[28] we won-
der whether the interaction between plasma proteins and dif-
ferent PSi NPs would account for the surface dependent in-
flammatory attenuation. We first evaluated the different protein
binding pattern from different PSi NPs. Blood plasma from ALI
and healthy mice was collected and incubated with different
PSi NPs to form the protein corona. Then, the whole plasma
proteins from healthy mice, ALI mice and proteins in corona
were separated by sodium dodecyl sulphate-polyacrylamide gel
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Figure 3. Immuno-modulation effects of different PSi NPs under ALI condition. a) Effect of PSi NPs administration on pro-inflammatory cytokines
mRNA synthesis. The mRNA expression levels of each cytokines from healthy mice were fixed as 1. TO at high concentration could reduce the TNF-𝛼
and IL-6 mRNA expression, whereas Un at high concentration could reduce TNF-𝛼, IL-6, and IL-1𝛽 mRNA expression comparing to ALI group. Inhibition
effect of PSi NPs on ALI-mediated pro-inflammatory cytokines (TNF-𝛼, IL-6, and IL-1𝛽) release. b) TNF-𝛼 production could be reduced by TO L, TO h,
TC h, Un L, and Un H treatment; c) IL-6 production could be reduced by TO L, TO h, Un L, and Un H treatment; d) IL-1𝛽 production could be reduced
by TO h, TC L, and Un H treatment. All data in the graphs are shown as mean ± SD from five independent replicates. *p < 0.05, **p < 0.01, ***p <
0.0005, and ****p < 0.0001 compared with ALI group (two-tailed Student’s t-test).
electrophoresis. Amacroscopic difference in protein-binding pat-
tern was observed from different PSi protein corona (Figure
S4a,b, Supporting Information), and relative intensity of each
bands zone (relative densitometry) was calculated to evaluate this
difference in amore detailedmanner (Figure S4c, Supporting In-
formation), which confirmed an altered protein corona composi-
tion from different PSi NPs.
To further confirm that PSi with different surface chemistries
altered protein binding capability, we investigated whether PSi
might potentially associate with pro-inflammatory proteins, such
as cytokines, and we separately evaluated the absorption of three
main pro-inflammatory cytokines (TNF-𝛼, IL-1𝛽, and IL-6) to dif-
ferent PSi NPs. Different PSi NPs were separately incubated with
TNF-𝛼, IL-1𝛽, and IL-6 stock solution and the detailed cytokine
binding capability wasmeasured throughELISAmethod. Results
suggested different from TC and Un, only TO obtained a concen-
tration dependent absorption capability for IL-1𝛽, whereas Un
exhibited a statistically significant IL-6 absorption (Figure S4d,
Supporting Information). These results indicated that different
PSi NPs had a prominent discrepancy between protein binding
patterns. However, the results have not been conclusive enough
for an understanding of the correlation between this difference
and the biological phenomenon.
As such, we further adapted a quantitative proteomic method
to unravel the detailed composition of the protein corona from
each type of PSi NPs. Isobaric tags for TMT method is par-
ticularly useful for comparative quantitative analysis, and en-
ables more accurate and multiplexed quantification comparing
to conventional methods, such as isotope coded affinity tags
procedure.[29,30] Different PSi NPs were incubated with plasma
extracted from ALI mice, and the proteins from the corona-
complex were further eluted for analysis, as described previously
with slight modification.[30] As a result, we obtained a large pro-
teome datasets of 4459 types of proteins identified from all three
types of corona complex, which is significantly higher than pre-
vious reports.[31] The amount of the database is the critical pre-
requisite for successful and accurate data mining, and therefore,
this enhanced number in identified proteins will further facil-
itate the following R-language based data analysis. Among the
totally identified types of proteins, 2123 types of proteins with p
< 0.05 were considered to obtain a significantly altered affinity
toward different PSi based on the one-way analysis of variance
(ANOVA) comparison. Further analysis was followed by a Stu-
dent’s t-test, and proteins with the p < 0.05 were selected and
classified by their major enrichment (given as “TO,” “TC,” or
“Un”). Among which, 1127 of themweremainly captured by TO,
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whereas the corresponding number for TC and Un were 483 and
513, separately (Data S1, Supporting Information). The proteins
enriched in each group were then subjected to Gene Ontology
analysis using the database for annotation, visualization, and in-
tegrated Discovery. R-language analysis was further applied to ex-
plore the protein binding pattern of different PSi NPs, these pro-
teins were first classified by their subcellular location (Figure 4a).
Results suggested that all types of PSi captured massive intracel-
lular proteins that were usually not observed in healthy plasma.
Noteworthy, the percentage of mitochondrial proteins within the
TO-corona complex (22.8%) was significantly higher than TC-
corona (13.9%) and Un-corona (12.5%), whereas the most distin-
guished feature for Un-corona was the high percentage of extra-
cellular proteins within its corona complex (TO-corona, 15.1%;
TC-corona, 11.0%; Un-corona, 28.5%).
Gene ontology (GO) analysis was further conducted based
on cellular component (CC) to demonstrate the biased proteins
binding pattern of different PSi. GO terms with false discover
rate (FDR) < 0.05 were considered as significant enrichment.
As shown in Figure 4b, for the proteins mainly captured by TO,
the most significant enrichment of CC is in mitochondrion (GO:
0005739, FDR = 7.49 × 10−48), suggesting TO had propensity to-
ward bindingmitochondrial proteins. Despite TC andUn did not
obtain distinct affinity toward any specific type of intracellular
proteins, Un showed a distinguished enrichment in absorbing
extracellular proteins (GO: 0005615, FDR = 1.81 × 10−34).
In total, 862 extracellular and secreted proteins were further
filtered (Data S2, Supporting Information), and then subjected
to biological process (BP) and molecular function (MF) anno-
tations to obtain their biological roles. Among which, response
to stimulus (GO: 0050896, FDR = 1.50 × 10−39), immune sys-
tem process (GO: 0002376, FDR = 4.40 × 10−39), and locomo-
tion (GO: 0040011, FDR = 1.30 × 10−32) were the most sig-
nificant enrichments of biological process; molecular function
modulator (GO: 0098772, FDR = 9.60 × 10−18), ligand binding
(GO: 0005488, FDR = 1.30 × 10−14), and chemoattractant (GO:
0042056, FDR = 3.50 × 10−7) were the most significant enrich-
ments of molecular function (Figure 4c). These results suggested
the pro-inflammatory properties of the captured proteins within
the corona-complex.
Within the overall 862 extracellular/secreted proteins, 244
types of proteins were directly associated with inflammatory
cascade and obtained enough abundance in all three types of
corona-complex for conducting relative quantification. This sub-
set of proteins not only contained the pro-inflammatory cytokines
and/or chemokines, but also massive damage-associated molec-
ular patterns (DAMPs), such as high mobility group protein B1
or heat shock proteins, which are commonly enriched in dam-
aged or inflamed tissues and further amplify the inflammatory
process.[32] To discover PSi surface chemistry specific protein ab-
sorption pattern, one-way ANOVA was performed. Within the
244 types of extracellular immune-regulatory proteins, 208 iden-
tified proteins with p < 0.05 were considered to obtain a signif-
icantly altered affinity between different PSi, as shown in the
heat map. By comparing relative abundance, 84 types of pro-
teins were mainly enriched in TO-corona and the correspond-
ing number for TC-corona and Un-corona were 33 and 91 (Fig-
ure 4d, Data S2, Supporting Information). Overall, these results
indicate a surface-based plasma protein absorption pattern of dif-
ferent PSi NPs. Among which, TO obtained the highest affin-
ity toward mitochondrial proteins, which is the major source of
DAMPs-induced inflammation, whereas Un showed better cap-
turing ability toward pro-inflammatory signaling proteins, and
this specific binding pattern might account for the improvement
of ALI prognosis.
To further confirm our hypothesis, we next checked whether
this protein scavenge induced immune-modulation was feasible
in vitro. Murine macrophage cell line RAW 264.7 were incubated
with Dulbecco’s modified Eagle’s medium (DMEM) containing
10%of healthymice plasma (further referred as healthymedium)
or ALImice plasma (referred as ALImedium). As a key signaling
pathway for modulating inflammation, immunoblot analysis of
nuclear factor 𝜅B (NF-𝜅B) pathway was carried out to evaluate the
immunomodulatory effect of PSi in presence of ALI plasma. As
shown in Figure 5a, the pro-inflammatory effect of ALI plasma
was confirmed as ALI medium enhanced the phosphorylation
of NF-𝜅B inhibitor, inhibitor 𝜅-B𝛼, upregulating the expression
of NF-𝜅B subunit transcription factor p65 (RELA), rendering a
pro-inflammatory cascade. However, ALI medium pre-incubated
with TO or Un, but not TC, showed a decreased NF-𝜅B activa-
tion comparing to blank ALI medium (Figure S5a, Supporting
Information)
The mRNA expression level associated with key pro-
inflammatory cytokines/chemokines were also evaluated via
qPCR. As shown in Figure S5b, Supporting Information, cells
treatedwith ALImediumexhibited a time-dependent elevation in
cytokines/chemokines expression and reached to peaks at 1.5 h,
except CXCL-1 with a peak at 2.5 h. We next examined whether
NPs’ corona formation might impact on the pro-inflammatory
cytokines/chemokines’ mRNA expression. ALI medium was
pre-incubated with different PSi at the concentration of 20
µg mL−1 for 4 h, then the PSi NPs containing ALI medium
were incubated with RAW 264.7 macrophage cells for another
1.5 h, while blank ALI medium was used as control. As shown
in Figure 5b, PSi treatment modulated the pro-inflammatory
effect of ALI medium in different extent, where TO showed an
enhanced IL-6 expression, but a decreased IL-1𝛽 expression;
TC only reduced IL-1𝛽 expression and Un downregulated the
expression of TNF-ɑ and IL-1𝛽. In particular, this phenomenon
was likely induced by the ALI plasma absorption as blank PSi
NPs administration induced a different expression profile of
these genes (Figure S5c, Supporting Information).
Further ELISA assays were carried out to decipher the detailed
immune-modulation functions of captured proteins in corona-
complex by quantitatively elucidating the cytokines release pro-
file. RAW 264.7 macrophage cells were separately treated with
healthy medium (Healthy); ALI medium (ALI); ALI medium
containing 20 µg mL−1 of TO (ALITO+), TC (ALITC+), and Un
(ALIUn+); ALI medium pre-treated with 20 µg mL−1 of TO, TC,
and Un for 4 h, followed by removing the NPs via centrifu-
gation (ALITO−, ALITC−, and ALIUn−) after 24 h. Comparing to
Healthy group, ALI group showed 7.0-fold of TNF-𝛼, 4.1-fold
of IL-6, and 3.7-fold of IL-1𝛽 excretion, confirming the pro-
inflammatory effects of plasma from ALI mice. PSi treatment
of ALI medium pervasively ameliorated its pro-inflammatory
effect, and the general inflammatory attenuation effect from
different PSi was TO ≈ Un > TC. As comparing to ALI
group, ALITO+ reduced 40% of TNF-𝛼 production, 68% of IL-6
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Figure 4. Quantification and comparison of different corona-complex identified by TMT and the following R-language facilitated analysis. a) Proteins
significantly absorbed by TO, TC, and Un identified and further classified by their subcellular location. Percentage of proteins from different subcellular
locations shown as the column chart (left panel) and doughnut chart (right panel). For the doughnut chart, the corresponding annulus represented
total, TO, TC, and Un (from inside to outside), respectively. b) Biased protein absorption pattern from different PSi NPs, GO annotation investigated
based on the CC term. c) The GO term enrichment of proteins identified from NPs’ corona complex and classified as extracellular/secreted according
to their subcellular location. Biological processes of GO terms and molecular functions of GO terms were separately investigated. d) In total 244 types
of extracellular/secreted proteins annotated as inflammation-related proteins and a heat map further plotted according to the relative amount of each
protein in different NPs’ corona complex, indicating a distinguished extracellular/secreted proteins binding pattern to different PSi NPs. Log-transformed
normalized peak intensities of proteins in each samples were expressed using red, black, or green colors in a heat map (n = 3).
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Figure 5. PSi treatment can modulate the immunostimulative effect of ALI plasma through protein corona formation. a) TO and Un downregulate ALI
plasma inducedNF-𝜅B activation inmacrophages. RAW 264.7macrophages cells treated 1 h with healthymedium, ALI medium, ALI medium pre-treated
and containing 20 µg mL−1 of different PSi NPs were subjected to immunoblotting assay. b) Treatment with PSi NPs attenuated ALI plasma induced
pro-inflammatory cytokines/chemokines mRNA synthesis. RAW 264.7 cells treated 1.5 h with ALI medium, ALI medium pre-treated and containing 20 µg
mL−1 of different PSi NPs. The mRNA expression levels of each cytokines from RAW 264.7 macrophages cells treated with blank ALI medium were fixed
as 1. c) Pro-inflammatory cytokines’ secretion profile of macrophages treated with healthy medium, ALI medium, ALI medium containing 20 µg mL−1 of
different PSi NPs (ALITO+, ALITC+, and ALIUn+) and ALI medium pre-incubated, but without containing 20 µg mL−1 of different PSi NPs (ALITO−, ALITC−,
and ALIUn−) for 24 h. Values are expressed as the means ± SDs of four independent trails. Statistical significance is assessed by two-tailed Student’s
t-test; *p < 0.05, **p < 0.01, ***p < 0.0005, and ****p < 0.0001. d) 20 µg mL−1 of different PSi NPs incubated with ALI medium for 4 h, followed by
centrifugation to recover the pellet. Macrophages were treated with blank DMEM, DMEM containing 20 µg mL−1 pristine PSi (TO-corona−, TC-corona−,
and Un-corona−) or DMEM containing 20 µg mL−1 recovered PSi pellets (TO-corona+, TC-corona+, and Un-corona+) after 24 h, and then the cytokines’
concentration in the supernatant measured afterward. The cytokine excretion level from DMEM group were fixed as 1. Values are expressed as the means
± SDs of four independent trails.
production, and 66% of IL-1𝛽 production. The corresponding
number for ALITC+ was 20%, 59%, and 58%, and the number for
ALIUn+ was 34%, 66%, and 66%. Moreover, ALITO−, ALITC−, and
ALIUn− also subsided inflammation activation. Besides of TNF-
𝛼, they exhibited an overall similar cytokines’ production profile
comparing to ALITO+, ALITC+, and ALIUn+, suggested inhibited
pro-inflammatory activities was likely due to pro-inflammatory
proteins adsorption onto the particle surfaces, as proposed in the
previous section (Figure 5c).
Previous studies reported the formation of protein corona
on NPs could either stimulate or suppress inflammatory re-
sponses in immune cells.[33,34] To test the role of the PSi-corona
Adv. Sci. 2020, 2001129 2001129 (8 of 12) © 2020 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
www.advancedsciencenews.com www.advancedscience.com
complex in determining the immunogenicity of PSi under ALI
condition, RAW 264.7 cells were separately treated with FBS
free DMEM medium (DMEM); FBS free DMEM medium con-
taining 20 µg mL−1 TO (TO-corona+), TC (TC-corona+), and
Un (Un-corona+) recovered from ALI medium treatment; FBS
free DMEM medium containing pristine TO (TO-corona-), TC
(TC-corona-), and Un (Un-corona-) for 24 h. Results suggest
PSi-corona complex exhibited non-superior cytokines produc-
tion comparing to pristine PSi, and TO-corona+ and TC-corona+
even showed less pro-inflammatory stimulation effects compar-
ing to their corresponding counterparts. Moreover, TO-corona+,
TC-corona+, and Un-corona+ only obtained limited immunos-
timulatory effects, as comparing to DMEM group, TO-corona+
exhibited 1.4-, 1.5-, and 1.0-fold higher production for TNF-𝛼,
IL-6, and IL-1𝛽, and the corresponding number for TC-corona+
were 1.3-, 1.0-, and 1.1-fold, and for Un-corona+ the respective
number were 1.6-, 1.8-, and 1.3-fold (Figure 5d). This suggest
the limited immunogenicity of the bare PSi-corona complex, fur-
ther confirmed PSi-absorption could block the biological activity
of the pro-inflammatory proteins. Overall, all these data suggest
that the blood plasma collected from ALI mice initiated a pro-
inflammatory process, whereas this effect was modulated by PSi
NPs due to the protein absorption and protein corona formation.
And this protein binding pattern was dependent on the surface
chemistry properties of PSi NPs.
The above-mentioned results suggested that PSi NPs can af-
fect the ALI prognosis through absorbing inflammatory-stimuli
proteins in plasma under a diseased condition. However, this
inflammation attenuation efficiency is not dictated by the sur-
face hydrophobicity of the PSi NPs, as different PSi NPs ob-
tained a significantly altered protein binding pattern, and no lin-
ear correlation between the hydrophobicity of the NPs and the
inflammatory-stimuli protein binding was revealed through the
R-language based machine analysis. To further explore the piv-
otal factor of NPs in determining this phenomenon, we hypoth-
esized whether PSi NPs, with the same surface chemistry but
different protein binding capability, could show different inflam-
mationmodulation efficiency. To confirm this, we separately syn-
thesized a new batch of TO, TC, and Un NPs (N-TO, N-TC, and
N-Un) with significantly reduced porosity (including specific sur-
face area, total pore volume and average pore diameter) compared
to the conventional PSi NPs (Table S2, Supporting Information).
The BCA assay confirmed that TO, TC and Un NPs obtained
higher protein binding capability compared to their correspond-
ing counterparts (N-TO, N-TC, and N-Un, Figure S6, Support-
ing Information). ELISA assays were further carried out to com-
pare the immune-modulation functions of two different batches
of PSi NPs. RAW 264.7 macrophage cells were separately treated
with ALI medium (ALI); ALI medium containing 20 µg mL−1
of TO (ALITO+), N-TO (ALINTO+), TC (ALITC+), N-TC (ALINTC+),
Un (ALIUn+), and N-Un (ALINUn+); ALI medium pre-treated with
20 µg mL−1 of TO, N-TO, TC, NTC, Un, and N-Un for 4 h, fol-
lowed by removing the NPs via centrifugation (ALITO−, ALINTO−,
ALITC−, ALINTC−, ALIUn-, and ALINUn−) after 24 h. Consistent with
the aforementioned results, all types of PSi NPs treatment atten-
uated the ALI plasma induced inflammation stimulation in dif-
ferent extents. Yet, the results showed that the new batch of PSi
NPs showed an overall lower inflammation attenuation efficiency
compared to their corresponding counterparts with higher poros-
ity and protein binding capability (Figure 6). This further consol-
idate our previous hypothesis that the “protein sweep” capabil-
ity of PSi NPs may be responsible for the inflammation attenua-
tion phenomenon under an ALI condition. Whereas this protein
binding affinity is positively correlated with the porosity of PSi
NPs, thus may further dictate the inflammation attenuation effi-
ciency in ALI.
We were asked whether the reductive nature of PSi NPs may
be responsible for ameliorating inflammation, as despite the sur-
face stabilization, the major part of PSi NPs is still composed
by reductive Si–Si bonds. And the reductive silicon bonds may
consume and scavenge ROS under inflammatory condition to
proceed to oxidation process, further facilitate the hydrolysis and
degradation (Figure S7a, Supporting Information),[4,35] as previ-
ous reports demonstrated the physiochemical nature of NPsmay
also partly determine their immunogenicity.[33,36] Indeed, the co-
incubation of PSi NPs and H2O2 can reduce the H2O2 amount
in a PSi concentration dependent manner (Figure S9a, Support-
ing Information). TO showed the most prominent scavenging
efficiency, whereas Un had a negligible effect, and the ranking
for scavenge effects from different PSi was TO > TC > Un. This
might be caused by the hydrophobic surface of TC and Un pre-
venting the surface wetting process, which was confirmed by the
WCA results (Table S1, Supporting Information). We further ob-
served the degradation kinetics of different PSi with or without
addition of extra ROS. As shown in Figure S7b, Supporting In-
formation, addition of ROS accelerated the PSi degradation in
different extent, and adding ROS into TO could enhance degra-
dation within 6 h, yet this phenomenon from TC was not statisti-
cally different until after 2 days, and Un only showed a statistical
significant difference at day 7. This could also be explained as,
the different hydrophobicity from TO, TC and Un determined
the NPs surface wetting efficiency, this may not only dictate the
interaction between ROS and the Si back bonds, but also affect
the following hydrolysis process.
ROS scavenge phenomenon was further investigated in
RAW 264.7 cells and the ROS levels were monitored by 2’,7’-
dichlorodihydrofluorescein diacetate fluorescence assay[37]. In
consistent with previous reports, TO, TC, and Un showed low
to no effects on the cellular viability of RAW 264.7 cells (Figure
S8a, Supporting Information).[12] Under normal condition, addi-
tion of TO, TC, and Un, independent of the NPs’ concentration,
showed no statistical significant effect on the intracellular ROS
levels (Figure S7c, Supporting Information), which is consistent
with the previous report[37]. We then evaluated the intracellu-
lar ROS perturbation effect of PSi NPs under an inflammatory
condition with lipopolysaccharide and interferon 𝛾 cotreatment,
which simulated the pro-inflammatory condition, triggeredmore
than twofold of ROS generation in RAW264.7 cells. However, the
sequential administration of PSi showed low to no effect on the
intracellular ROS content, suggesting that as observed ROS con-
sumption effect from PSi was not feasible in vitro (Figure S7d,
Supporting Information), and PSi NPs administration showed
no effect on the cellular morphology of RAW 264.7 cells (Figure
S8b, Supporting Information). This phenomenon was further
confirmed by the viability test, whereHepG2 liver carcinoma cells
were treated by various concentrations of H2O2 for 24 h. Simul-
taneous coadding all types of PSi NPs with H2O2 did not reverse
the H2O2 induced cellular apoptosis (Figure S9b,c, Supporting
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Figure 6. PSi with less porosity showed less immunostimulative modulation effect on ALI plasma. a) Pro-inflammatory cytokines’ secretion profile
of macrophages treated with healthy medium, ALI medium, ALI medium containing 20 µg mL−1 of TO, TC, Un (ALITO+, ALITC+, ALIUn+) or their
corresponding counterparts with less porosity but same surface chemistry (ALINTO+, ALINTC+, ALINUn+). b) Pro-inflammatory cytokines’ secretion profile
of macrophages treated with healthy medium, ALI medium, ALI medium pre-incubated, but without containing 20 µgmL−1 of different PSi NPs (ALITO−,
ALINTO−, ALITC−, ALINTC−, ALIUn-, and ALINUn−) for 24 h. Values are expressed as mean ± SEM of four independent trails. Statistical significance is
assessed by two-tailed Student’s t-test; *p < 0.05, **p < 0.01, and ***p < 0.0005.
Information). However, when we pre-incubated PSi with H2O2
containing medium for 24 h, followed by incubation of HepG2
cells with the corresponding medium, attenuated toxicity from
the H2O2 was observed in treatment group of the medium pre-
treated with TO (Figure S7e, Supporting Information). Together,
our results suggested that the ROS scavenge effect from PSi NPs
was a rather slow process and has limited effect on modulating
the intracellular ROS content in vitro.
Overall, using ALI mice model, we scrutinized the composi-
tion of protein corona around PSi NPs, followed by R-language
based molecular mechanism investigation, revealing the impor-
tant role of such protein corona in modulating immunogenicity.
These results were different from the observation under normal
physiological conditions that TO and TC showed good biocom-
patibility, while Un exhibited mild liver toxicity.[37,38]
Under ALI condition, acute phase proteins, mostly pro-
inflammatory signaling proteins, are abnormally secreted in
plasma.[27] Furthermore, massive intracellular proteins, which
are leaked to plasma after cellular damage and further function
as natural endogenous adjuvants to induce phlogosis,[39] and Un
and TO, comparing to TC, could better capture such kind of ex-
tracellular signaling proteins.
In summary, we have identified a significant role of protein
corona under diseased conditions in regulating the immuno-
genicity of PSi NPs. More importantly, this immunological im-
pact of PSi NPs is minimal related with the reductive nature of
PSi NPs, but more governed by their porosity, rather than surface
hydrophobicity. However, we should be noted that despite the fact
that we failed to find any liner correlation between surface hy-
drophobicity of NPs and the pro-inflammatory protein binding
capability, it has long been unraveled the pivotal role of surface
chemistry of NPs on dictating the specific protein binding.[19,40]
Therefore, further efforts should be made to achieve a “designed
adsorption” via NPs with specific surface chemistries.[41] This
may provide insights for designing PSi NPs based pharmaceuti-
cal products, further facilitate its clinical translation, meanwhile
offering alternative perspective for evaluating the biocompatibil-
ity of other NPs in pathological circumstances.
Experimental Section
All the experimental details are reported in the Supporting Information.
A list of abbreviations and variations are listed in Table S3. All experiments
involving animals were performed in compliance with the guidelines from
the Institutional Animal Care and Use Committee at Experimental Animal
Centre in Xiamen University, China.
Supporting Information
Supporting Information is available from the Wiley Online Library or from
the author.
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